Study finds previously unidentified genetic mutation in a small protein provides significant protection against Parkinson’s disease

FHS
January 4, 2024
10:43 am

Researchers explored the effects of a small humanin-like peptide 2 (SHLP2) variant on mitochondrial function.

Persistent activation of DNA damage response in the liver after MASLD reversal

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its more advanced form, metabolic dysfunction-associated steatohepatitis, have emerged as the most prevalent liver diseases worldwide.

October 25, 2024

Astellas agrees to take over Propella Therapeutics for $175m

Share this article Astellas plans to fund the acquisition of Propella using cash on hand. Credit: JHVEPhoto / Shutterstock.com. Astellas Pharma has signed an agreement for

November 16, 2023

Researchers link air pollution to cerebral atrophy but find no impact on cognitive function

Exposure to mid- to high-range PM2.5 is linked to cerebral atrophy, but there is no significant impact on cognitive function. The findings suggest that urbanization

October 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.